Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2007. Start Trial.
Date Value
September 21, 2026 0.0445
September 18, 2026 0.0445
September 17, 2026 0.0445
September 16, 2026 0.0445
September 15, 2026 0.0445
September 14, 2026 0.0445
September 11, 2026 0.0445
September 10, 2026 0.0445
September 09, 2026 0.0445
September 08, 2026 0.0445
September 04, 2026 0.0445
September 03, 2026 0.0445
September 02, 2026 0.0445
September 01, 2026 0.0445
August 31, 2026 0.0445
August 28, 2026 0.0445
August 27, 2026 0.0445
August 26, 2026 0.0445
August 25, 2026 0.0445
August 24, 2026 0.0445
August 21, 2026 0.0445
August 20, 2026 0.0445
August 19, 2026 0.0445
August 18, 2026 0.0445
August 17, 2026 0.0445
Date Value
August 14, 2026 0.0445
August 13, 2026 0.0445
August 12, 2026 0.0445
August 11, 2026 0.0445
August 10, 2026 0.0445
August 07, 2026 0.0445
August 06, 2026 0.0445
August 05, 2026 0.0445
August 04, 2026 0.0445
August 03, 2026 0.0445
July 31, 2026 0.0445
July 30, 2026 0.0445
July 29, 2026 0.0445
July 28, 2026 0.0445
July 27, 2026 0.0445
July 24, 2026 0.0445
July 23, 2026 0.0445
July 22, 2026 0.0445
July 21, 2026 0.0445
July 20, 2026 0.0445
July 17, 2026 0.0445
July 16, 2026 0.0445
July 15, 2026 0.0445
July 14, 2026 0.0445
July 13, 2026 0.0445

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
DBV Technologies SA 2.801
Cellectis SA 3.065
Genfit SA --
Innate Pharma SA --
Inventiva SA 1.785

Price to Book Value Related Metrics

Price 0.30
Market Cap 26.44M